Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Santen Pharmaceutical Co., Ltd. is a global company dedicated to ophthalmology, developing and marketing a wide range of pharmaceutical products and medical devices for eye care. With a history spanning over a century, Santen focuses on addressing unmet medical needs in eye health, from common conditions to rare diseases. The company is committed to research and development, aiming to deliver innovative solutions to protect and improve vision for patients worldwide. Santen's operations cover Japan, Asia, Europe, and the Americas, reflecting its commitment to being a global leader in eye care.
The global headquarters serves as the central hub for Santen's worldwide operations, including strategic planning, corporate governance, global R&D oversight, and core administrative functions.
Located in Grand Front Osaka, a prominent mixed-use complex adjacent to Osaka Station, offering modern facilities and excellent connectivity.
The work culture at Santen's headquarters emphasizes precision, innovation, and a strong commitment to patient well-being, reflecting its Japanese heritage and global pharmaceutical standards. Collaboration and dedication to scientific advancement are key aspects.
The Osaka headquarters is significant as it anchors Santen's long history in Japan and directs its global strategy in the specialized field of ophthalmology, driving innovation and market expansion.
Santen supports a wide range of functions globally, including research and development of novel ophthalmic therapies, manufacturing of sterile eye care products, commercial sales and marketing operations in over 60 countries, medical affairs, regulatory compliance, and strategic partnerships. Its global network ensures that innovative treatments for eye diseases reach patients worldwide.
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku
Osaka
Osaka Prefecture
Japan
Address: 6401 Hollis Street, Suite 125, Emeryville, CA 94608, USA
Strategic hub for Santen's presence and growth in the United States, a key market for advanced ophthalmic treatments.
Address: Keljonkatu 3, 33100 Tampere, Finland
Key European manufacturing and R&D center, contributing to product supply and development for Europe and other global markets.
Address: 1 Wallich Street, #09-01 Guoco Tower, Singapore 078881
Drives Santen’s growth and market penetration in the dynamic APAC region, adapting global strategies to local healthcare needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Santen' leadership includes:
Santen has been backed by several prominent investors over the years, including:
Santen has seen some key appointments in its executive team over the past year, strengthening its R&D and strategic leadership. Publicly announced departures at the top executive level have been minimal.
Discover the tools Santen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Santen commonly uses a combination of first name and last name, or first initial and last name, for its email formats. The most prevalent patterns are 'firstname.lastname@santen.com' and 'f.lastname@santen.com'.
[first].[last]@santen.com or [f].[last]@santen.com
Format
jane.doe@santen.com or j.doe@santen.com
Example
85%
Success rate
Santen News Release • April 26, 2024
Santen reported its consolidated financial results for FY2023, highlighting revenue growth driven by key products in Japan and EMEA, alongside updates on its R&D pipeline and strategic initiatives for sustainable growth....more
Santen News Release • March 28, 2024
Santen announced an organizational realignment effective April 1, 2024, aimed at accelerating its 2030 Vision by strengthening R&D capabilities and optimizing global operations. This included the appointment of Hitomi Nakayama as Chief R&D Officer....more
Santen News Release • February 19, 2024
Santen announced it received manufacturing and marketing approval in Japan for DIQUAS™ LX Ophthalmic Solution 3% (diquafosol sodium), a treatment for dry eye, offering a new option with improved persistence on the ocular surface....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Santen, are just a search away.